Pharma, Devices & More: Inside the Future of Glaukos

This week on The Rob & Jai Show , an edition of the OIS Podcast, Dr. Rob Rothman and Dr. Jai Parekh welcome Tomas Navratil, PhD, Chief Development Officer at Glaukos, to discuss the company’s remarkable transformation from MIGS pioneer to a diversified global leader in ophthalmology. Glaukos is advancing a robust pipeline that spans devices, pharmaceuticals, and drug-device combinations—reshaping the future of eye care. Highlights from the episode include: How Glaukos tripled its R&D pipeline over the past decade A shift from 100% device focus to 70% pharma or drug-device innovation Next-gen iDose TR with double the payload heading into clinical development Positive Phase 3 results for Epioxa, a non-surgical therapy for keratoconus Tune in now to hear how Glaukos is stepping into its next chapter as a true ophthalmic powerhouse.

You can listen to Pharma, Devices & More: Inside the Future of Glaukos online on Radio and Podcast. Open the player on this page to stream the available audio.

Pharma, Devices & More: Inside the Future of Glaukos is an episode from OIS Podcast by OIS Podcast.

This episode is 10:13 long.

This episode was published on Jun 6, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from OIS Podcast when more episodes are available from the podcast feed.